Novartis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. 

CEO
Vasant Narasimhan
CEOVasant Narasimhan
Employees
75,267
Employees75,267
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1996
Founded1996
Employees
75,267
Employees75,267

NVS Key Statistics

Market cap
332.97B
Market cap332.97B
Price-Earnings ratio
31.34
Price-Earnings ratio31.34
Dividend yield
1.87%
Dividend yield1.87%
Average volume
2.50M
Average volume2.50M
High today
$165.96
High today$165.96
Low today
$163.05
Low today$163.05
Open price
$163.24
Open price$163.24
Volume
1.10M
Volume1.10M
52 Week high
$170.46
52 Week high$170.46
52 Week low
$123.24
52 Week low$123.24

NVS News

The Motley Fool 2d
Novartis: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Oct. 27, 2026, Novartis (NVS -1.40%) raised its full-year 2026 core operating income guidance after delivering...

Novartis: 3 Key Takeaways for Long-Term Investors
Reuters 3d
Novartis heart drug failure leaves doctors seeking evidence for genetic cholesterol target - Reuters

...

Novartis heart drug failure leaves doctors seeking evidence for genetic cholesterol target - Reuters
Zacks 6d
All You Need to Know About Novartis Rating Upgrade to Buy

Investors might want to bet on Novartis (NVS Quick QuoteNVS - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is ess...

All You Need to Know About Novartis Rating Upgrade to Buy

Analyst ratings

63%

of 8 ratings
Buy
62.5%
Hold
37.5%
Sell
0%

More NVS News

Zacks 6d
Why Novartis is a Top Momentum Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways...

Why Novartis is a Top Momentum Stock for the Long-Term

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.